Ramsay Health Care Limited
RMYHYOTCHealthcare● Active
$6.98
+$0.00(+0.00%)
Market Cap$6.4B
P/E Ratio—
52W High$7.175
52W Low$4.31
Ramsay Health Care Limited (RMYHY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
RMYHY · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 25, 2026EPS Actual
$0.11
Revenue
$6.12B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 25, 2026
After Market Close
RMYHY reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 25, 2026 | — | $0.11 | — | $6.12B | — | — |
| — Q3 FY2025 | Aug 28, 2025 | — | $0.09 | — | $6.06B | — | — |
| — Q1 FY2025 | Feb 27, 2025 | — | -$0.28 | — | $5.29B | — | — |
| — Q3 FY2024 | Aug 29, 2024 | — | $0.38 | — | $5.72B | — | — |
| — Q1 FY2024 | Feb 29, 2024 | — | $2.26 | — | $5.51B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.30 | — | $5.23B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.58 | — | $4.86B | — | — |
| — Q2 FY2022 | Jun 30, 2022 | — | $0.35 | — | $4.61B | — | — |
Q1 FY2026
Feb 25, 2026
EPS Actual
$0.11
EPS Est.
—
EPS Surpr.
—
Revenue
$6.12B
Q3 FY2025
Aug 28, 2025
EPS Actual
$0.09
EPS Est.
—
EPS Surpr.
—
Revenue
$6.06B
Q1 FY2025
Feb 27, 2025
EPS Actual
-$0.28
EPS Est.
—
EPS Surpr.
—
Revenue
$5.29B
Q3 FY2024
Aug 29, 2024
EPS Actual
$0.38
EPS Est.
—
EPS Surpr.
—
Revenue
$5.72B
Q1 FY2024
Feb 29, 2024
EPS Actual
$2.26
EPS Est.
—
EPS Surpr.
—
Revenue
$5.51B
Q2 FY2023
Jun 30, 2023
EPS Actual
$0.30
EPS Est.
—
EPS Surpr.
—
Revenue
$5.23B
Q4 FY2022
Dec 31, 2022
EPS Actual
$0.58
EPS Est.
—
EPS Surpr.
—
Revenue
$4.86B
Q2 FY2022
Jun 30, 2022
EPS Actual
$0.35
EPS Est.
—
EPS Surpr.
—
Revenue
$4.61B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 25, 2026 | — | $6.80 | $6.80 | +0.00% |
| — Q3 FY2025 | Aug 28, 2025 | — | $5.71 | $5.71 | +0.00% |
| — Q1 FY2025 | Feb 27, 2025 | — | $5.56 | $5.56 | +0.00% |
| — Q3 FY2024 | Aug 29, 2024 | — | $7.42 | $7.42 | +0.00% |
| — Q1 FY2024 | Feb 29, 2024 | — | $7.87 | $7.87 | +0.00% |
| — Q2 FY2023 | Jun 30, 2023 | — | $9.31 | $9.31 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $11.28 | $11.28 | +0.00% |
| — Q2 FY2022 | Jun 30, 2022 | — | $12.98 | $12.19 | -6.09% |
Q1 FY2026+0.00%
Report Date
Feb 25, 2026
EPS Beat/Miss
—
Price Before
$6.80
Price After
$6.80
Q3 FY2025+0.00%
Report Date
Aug 28, 2025
EPS Beat/Miss
—
Price Before
$5.71
Price After
$5.71
Q1 FY2025+0.00%
Report Date
Feb 27, 2025
EPS Beat/Miss
—
Price Before
$5.56
Price After
$5.56
Q3 FY2024+0.00%
Report Date
Aug 29, 2024
EPS Beat/Miss
—
Price Before
$7.42
Price After
$7.42
Q1 FY2024+0.00%
Report Date
Feb 29, 2024
EPS Beat/Miss
—
Price Before
$7.87
Price After
$7.87
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$9.31
Price After
$9.31
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$11.28
Price After
$11.28
Q2 FY2022-6.09%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$12.98
Price After
$12.19
Beat Rate0 / 8 quarters
Largest Move-6.09% (Q2 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: RMYHY ends December
Ramsay Health Care Limited (RMYHY) most recently reported earnings on February 25, 2026 for Q1 FY2026, posting EPS of $0.11 (in line with the analyst consensus of —). The next RMYHY earnings date is expected around September 1, 2026.
Each quarter, investors track RMYHY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. RMYHY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
RMYHY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
RMYHY earnings · 4 questionsRamsay Health Care Limited's next earnings report is expected around September 1, 2026. RMYHY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; RMYHY historically reports after market close (AMC).
RMYHY earnings datewhen is RMYHY earningsRMYHY next earnings datewhen does RMYHY report earningsRMYHY earnings calendar
▸ Source: FMP · Ramsay Health Care Limited SEC filings · US GAAP · Ramsay Health Care Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026